Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 5

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 24, Issue 5 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 5 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Prospects for early investigational therapies for sickle cell disease

Nicola Conran

Pages: 595-602

Published online: 15 Feb 2015

AbstractforProspects for early investigational therapies for sickle cell disease | Full Text | References | PDF (278.1 KB)

1837 Views
11 CrossRef citations
0Altmetric

Free Access

Review

Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

Jacek Rysz (Professor) MD PhD FASN, Anna Gluba-Brzózka, Dimitri P Mikhailidis & Maciej Banach

Pages: 603-610

Published online: 21 Jan 2015

AbstractforFibroblast growth factor 19-targeted therapies for the treatment of metabolic disease | Full Text | References | PDF (298.1 KB)

443 Views
15 CrossRef citations
0Altmetric

Early investigational drugs targeting PPAR-α for the treatment of metabolic disease

Zhong-Min Liu MD PhD, Miao Hu (Research Assistant Professor) PhD, Paul Chan (Consultant Cardiologist) MD PhD & Brian Tomlinson (Professor of Medicine and Therapeutics) MBBS MD

Pages: 611-621

Published online: 21 Jan 2015

AbstractforEarly investigational drugs targeting PPAR-α for the treatment of metabolic disease | Full Text | References | PDF (399.6 KB)

950 Views
39 CrossRef citations
0Altmetric

Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke

Craig J Smith MD MRCP, Adam Denes PhD, Pippa J Tyrrell MD FRCP & Mario Di Napoli MD

Pages: 623-643

Published online: 01 Mar 2015

AbstractforPhase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke | Full Text | References | PDF (485.7 KB)

561 Views
28 CrossRef citations
0Altmetric

Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II

Narihito Nagoshi & Michael G Fehlings

Pages: 645-658

Published online: 03 Feb 2015

AbstractforInvestigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II | Full Text | References | PDF (481.1 KB)

794 Views
29 CrossRef citations
0Altmetric

Investigational drugs under development for the treatment of PTSD

Benjamin J Ragen, Jordan Seidel, Christine Chollak, Robert H Pietrzak & Alexander Neumeister (Professor of Psychiatry and Radiology, Director) MD

Pages: 659-672

Published online: 14 Mar 2015

AbstractforInvestigational drugs under development for the treatment of PTSD | Full Text | References | PDF (467.2 KB)

1003 Views
19 CrossRef citations
0Altmetric

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics

Jennifer Arrondeau, Olivier Huillard, Camille Tlemsani, Anatole Cessot, Pascaline Boudou-Rouquette, Benoit Blanchet, Audrey Thomas-Schoemann, Michel Vidal, Jean-Marie Tigaud, Jean-Philippe Durand, Jerome Alexandre & Francois Goldwasser

Pages: 673-687

Published online: 20 Jan 2015

AbstractforInvestigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics | Full Text | References | PDF (404.3 KB)

364 Views
7 CrossRef citations
0Altmetric

Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections

Burhan A Khan (Post-baccalaureate IRTA) BS, Anthony J Yeh (Post-baccalaureate IRTA) BS, Gordon Yc Cheung (Staff Scientist) PhD & Michael Otto (Senior Investigator) PhD

Pages: 689-704

Published online: 23 Feb 2015

AbstractforInvestigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections | Full Text | References | PDF (567.6 KB)

884 Views
68 CrossRef citations
0Altmetric

Drug Evaluation

The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms

Giulio Perugi MD, Giuseppe Quaranta MD & Nunzio Bucci MD

Pages: 705-713

Published online: 01 Mar 2015

AbstractforThe use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms | Full Text | References | PDF (297 KB)

357 Views
4 CrossRef citations
0Altmetric

Blinatumomab for the treatment of B-cell lymphoma

Eunhye Oak BA & Nancy L Bartlett (Professor of Medicine, Koman Chair in Medical Oncology) MD

Pages: 715-724

Published online: 04 Mar 2015

AbstractforBlinatumomab for the treatment of B-cell lymphoma | Full Text | References | PDF (298.6 KB)

1142 Views
25 CrossRef citations
0Altmetric

Ezatiostat hydrochloride for the treatment of myelodysplastic syndromes

Daruka Mahadevan MD PhD & Gregory Ryan Sutton MD

Pages: 725-733

Published online: 27 Feb 2015

AbstractforEzatiostat hydrochloride for the treatment of myelodysplastic syndromes | Full Text | References | PDF (459.1 KB)

370 Views
28 CrossRef citations
0Altmetric

Erratum

Correction

Erratum

Page: 735

Published online: 13 Mar 2015

CitationforErratum | Full Text | PDF (30.6 KB)

436 Views
2 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus

Eric F. Morand et al.

Plain Language Summary of Publication | Published online: 29 May 2024

Open Access

Inflammation and Huntington’s disease – a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 29 May 2024

Open Access

Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration

Shogo Hashimoto et al.

Review Article | Published online: 29 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.5, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?

Information for

Authors
R&D professionals
Editors
Librarians
Societies

Open access

Overview
Open journals
Open Select
Dove Medical Press
F1000Research

Opportunities

Reprints and e-prints
Advertising solutions
Accelerated publication
Corporate access solutions

Help and information

Help and contact
Newsroom
All journals
Books

Keep up to date

Register to receive personalised research and resources by email

Sign me up

Taylor and Francis Group Facebook page

Taylor and Francis Group X Twitter page

Taylor and Francis Group Linkedin page

Taylor and Francis Group Youtube page

Taylor and Francis Group Weibo page

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG

Citation search

Your download is now in progress and you may close this window

Login or register to access this feature

Expert Opinion on Investigational Drugs, Volume 24, Issue 5 (2015)

Expert Opinion on Investigational Drugs, Volume 24, Issue 5 (2015)

Editorial

Review

Drug Evaluation

Erratum

Further Readings

Explore articles

Download citations

Choose format

Access Rights

Information for

Open access

Opportunities

Help and information

Keep up to date